Welcome to our dedicated page for Ge Healthcare Technologies SEC filings (Ticker: GEHC), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
GE HealthCare Technologies Inc. filings document formal disclosures for a medical technology and diagnostics company, including Form 8-K reports on results of operations and financial condition, material agreements, capital-structure matters, and governance changes. Recent current reports include earnings releases, a senior unsecured revolving credit facility, and board-related disclosures.
The company’s proxy materials describe annual-meeting matters, director elections, board committee assignments, executive compensation, equity awards, and shareholder voting procedures. GEHC filings also provide formal context for segment performance, liquidity arrangements, credit covenants, and governance matters tied to its healthcare technology, software, and pharmaceutical diagnostics businesses.
Lobo Kevin reported acquisition or exercise transactions in this Form 4 filing.
GE HealthCare Technologies Inc. director Kevin Lobo reported an equity award of restricted stock units covering 3,586 shares of common stock. The award represents a grant, not an open-market purchase, and increased his direct holdings to 4,363 shares.
The filing notes that 100% of these restricted stock units will vest on the earlier of the company’s next annual meeting of stockholders or May 7, 2027. Each unit delivers one share of GE HealthCare common stock at settlement, and settlement may be deferred under the company’s Non-Employee Director Compensation and Benefits Plan.
Madden Anne T reported acquisition or exercise transactions in this Form 4 filing.
GE HealthCare Technologies Inc. director Anne T. Madden reported equity compensation awards in the form of company stock. She received 2,282 restricted stock units that will vest 100% on the earlier of the next GE HealthCare annual stockholder meeting or May 7, 2027. She also received 3,586 fully vested deferred stock units after electing to take her cash retainer as stock units under the Non-Employee Director Compensation and Benefits Plan. Each unit represents the right to receive one share of GE HealthCare common stock at settlement, and settlement of vested units may be deferred according to her plan elections. Following these awards, one transaction line shows she directly holds 19,479 shares of common stock.
GE HealthCare Technologies Inc. director William J. Stromberg reported a compensation-related equity grant. On May 7, 2026, he acquired 3,586 restricted stock units (RSUs), each representing one future share of common stock. These RSUs vest 100% on the earlier of the company’s next annual stockholder meeting or May 7, 2027. Stromberg can elect to defer settlement under GE HealthCare’s Non-Employee Director Compensation and Benefits Plan, meaning the actual delivery of shares can occur later according to his deferral election. Following this award, his direct holdings reported in this filing total 18,916 shares of common stock.
GE HealthCare Technologies Inc. held its annual stockholder meeting on May 7, 2026, where eight directors were elected to one-year terms. Vote totals for each nominee were strong, with Peter J. Arduini receiving 363,637,737 votes for and H. Lawrence Culp, Jr. receiving 351,620,004 votes for.
Stockholders approved the advisory vote on named executive officer compensation with 351,099,781 votes for and 12,973,200 against. They also ratified Deloitte & Touche LLP as independent auditor for the fiscal year ending December 31, 2026, with 398,257,878 votes for and 769,608 against.
Effective May 7, 2026, the Board appointed Rodney F. Hochman as independent lead director and named Anne T. Madden as chairperson of the Nominating and Governance Committee, signaling updated leadership roles within the board structure.
GE HealthCare Technologies director H. Lawrence Culp Jr. reported an open-market purchase of 80,805 shares of common stock at a weighted average price of $61.8783 per share, with individual trades between $61.50 and $62.22. Following this transaction, he indirectly holds 151,207 shares through a holding company, 328,268 shares through family trusts, and 12,699 shares directly.
GE HealthCare Technologies Inc. director William J. Stromberg reported an open-market purchase of company stock. On May 6, 2026, he bought 1,000 shares of common stock at $61.6892 per share, bringing his directly held ownership to 15,330 shares after the transaction.
GE HealthCare Technologies Inc. executive Catherine Estrampes, Chief Commercial & Growth Officer, reports beneficial ownership of 24,081 shares of common stock. This includes 14,374 shares plus restricted stock units that may settle into additional shares as they vest.
She also holds multiple employee stock options on GE HealthCare common stock. These options cover underlying share amounts such as 16,398 shares at an exercise price of $80.16 expiring on March 2, 2036, and 9,923 shares at $86.45 expiring on March 3, 2035, along with several other grants with different prices and expirations.
GE HealthCare Technologies Inc. Chief Financial Officer James Saccaro purchased 3,310 shares of Common Stock in an open-market transaction on May 1, 2026 at a weighted average price of $60.5997 per share. Following this purchase, he directly owns 87,471 shares. The filing notes the shares were bought in multiple trades at prices ranging from $60.59 to $60.60 per share.
GE HealthCare Technologies Inc. General Counsel and Corporate Secretary Frank R. Jimenez reported an open-market purchase of 1,750 shares of common stock at a price of $60.45 per share. Following this transaction, he directly owns 93,932 shares of GE HealthCare common stock.
GE HealthCare Technologies Inc. President and CEO Peter J. Arduini made an open-market purchase of company stock. On this date, he bought 4,169 shares of common stock at $59.925 per share.
After this transaction, Arduini directly owns 259,424 shares of GE HealthCare common stock. This filing shows a net increase in his personal shareholding through a straightforward open-market purchase.